Media

Learn more about us in our featured news stories and insights into the work that we do.

News Press Releases Locus Insights

March 8, 2021

New clinical trial data from Locus Biosciences shows promise in CRISPR-Cas3 technology

Learn More
March 5, 2021

Could this Research Triangle Park company hold a key to fighting drug-resistant bacteria?

Learn More
February 24, 2021

Locus Biosciences completes first-of-its-kind controlled clinical trial for CRISPR-enhanced bacteriophage therapy

Learn More
February 24, 2021

Genetically enhanced antibiotic from RTP firm advances in first-of-its-kind clinical trial

Learn More
December 17, 2020

Gene editing success could turn Triangle startup Locus Biosciences into a billion dollar unicorn

Learn More
November 10, 2020

Locus Biosciences signs contract with CARB-X to advance $14 million precision medicine program to develop crPhage™ product targeting Klebsiella pneumoniae infections

Learn More
September 30, 2020

Locus Biosciences signs contract with BARDA to advance $144 million precision medicine program to develop LBP-EC01, a crPhage™ product

Learn More
August 3, 2020

CRISPR Startups Give Genome Editing Several New Twists

Learn More
June 29, 2020

The First Controlled Clinical Trial For A CRISPR Enhanced Bacteriophage Therapy

Learn More
January 8, 2020

Locus Biosciences initiates world’s first controlled clinical trial for a CRISPR enhanced bacteriophage therapy

Learn More

Careers

We are on a mission to revolutionize the treatment of disease. We need intelligent, open, hard-working people who thrive in a fast-paced environment to join us on our quest.